CA
BIIB icon

Clearstead Advisors’s Biogen BIIB Stock Holding History

Clearstead Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$263K Sell
1,217
-1,306
-52% -$250K ﹤0.01% 974
2026
Q1 		$463K Buy
2,523
+274
+12% +$50.5K ﹤0.01% 731
2025
Q4 		$396K Buy
2,249
+747
+50% +$122K 0.01% 726
2025
Q3 		$210K Sell
1,502
-181
-11% -$24.5K ﹤0.01% 871
2025
Q2 		$211K Buy
1,683
+490
+41% +$61.1K ﹤0.01% 880
2025
Q1 		$163K Buy
1,193
+75
+7% +$10.7K ﹤0.01% 881
2024
Q4 		$171K Sell
1,118
-302
-21% -$50.9K ﹤0.01% 902
2024
Q3 		$275K Sell
1,420
-37
-3% -$7.74K ﹤0.01% 751
2024
Q2 		$338K Buy
1,457
+16
+1% +$3.48K 0.01% 635
2024
Q1 		$325K Sell
1,441
-387
-21% -$90.6K 0.02% 388
2023
Q4 		$473K Buy
1,828
+114
+7% +$28K 0.03% 317
2023
Q3 		$441K Buy
1,714
+266
+18% +$71.1K 0.03% 306
2023
Q2 		$412K Sell
1,448
-3
-0.2% -$893 0.03% 316
2023
Q1 		$403K Sell
1,451
-2
-0.1% -$553 0.03% 291
2022
Q4 		$402K Hold
1,453
– – 0.03% 283
2022
Q3 		$388K Hold
1,453
– – 0.04% 269
2022
Q2 		$296K Hold
1,453
– – 0.02% 322
2022
Q1 		$306K Buy
1,453
+226
+18% +$49.1K 0.02% 345
2021
Q4 		$294K Buy
1,227
+213
+21% +$54.8K 0.02% 330
2021
Q3 		$287K Hold
1,014
– – 0.02% 320
2021
Q2 		$351K Buy
1,014
+492
+94% +$149K 0.03% 267
2021
Q1 		$146K Buy
522
+138
+36% +$37.2K 0.01% 370
2020
Q4 		$94K Hold
384
– – 0.01% 424
2020
Q3 		$109K Buy
384
+114
+42% +$31.8K 0.01% 360
2020
Q2 		$72K Hold
270
– – 0.01% 391
2020
Q1 		$85K Buy
+270
New +$81.9K 0.01% 346

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Clearstead Advisors's BIIB Position: Q2 2026 in Review

Clearstead Advisors reduced its Biogen (BIIB) stake by 52% in Q2 2026, selling an estimated $250K and leaving 1,217 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #974.

Clearstead Advisors first reported a position in BIIB in Q1 2020 and has held it in 26 quarters since. The position peaked at $473K in Q4 2023. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Clearstead Advisors held 1,217 shares of Biogen worth $263K as of Q2 2026.
  • Clearstead Advisors sold 1,306 Biogen shares in Q2 2026, an estimated $250K.
  • Biogen made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #974 holding.
  • Clearstead Advisors first reported a position in Biogen in Q1 2020 and has held it in 26 quarters since.
  • Clearstead Advisors's Biogen position peaked at $473K in Q4 2023.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.